--- title: "Margin Over Volume: How Xylem and Levi Strauss Navigate the 2026 Earnings Season" type: "News" locale: "en" url: "https://longbridge.com/en/news/294333804.md" description: "Cross-sector leaders like Xylem and Levi Strauss are demonstrating strong earnings resilience. As top-line growth slows, institutional capital is rotating toward assets with proven price realization capabilities." datetime: "2026-07-30T09:14:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294333804.md) - [en](https://longbridge.com/en/news/294333804.md) - [zh-HK](https://longbridge.com/zh-HK/news/294333804.md) --- # Margin Over Volume: How Xylem and Levi Strauss Navigate the 2026 Earnings Season Cross-sector companies from water technology to consumer apparel are increasingly prioritizing margin expansion over top-line growth in their mid-2026 financial results, with firms like Xylem and Levi Strauss raising full-year profit forecasts despite softer sales volumes, according to recent corporate filings and market data. ### Xylem Inc. (XYL.US) Xylem is targeting higher profitability driven by a robust USD 5.30 billion backlog and AI-related industrial water demand. The company reported second-quarter 2026 revenue of USD 2.34 billion, and raised its full-year adjusted EPS guidance to a range of USD 5.55 to USD 5.70, according to recent statements. Despite lowering its full-year revenue outlook to roughly USD 9.20 billion, the stock has outperformed the broader market this year. ### Levi Strauss & Company (LEVI.US) Levi Strauss reported second-quarter 2026 adjusted earnings of USD 0.28 per share, beating consensus estimates, and raised its full-year earnings forecast to between USD 1.46 and USD 1.52 per share. Global revenue rose 8% year-over-year to USD 1.56 billion, buoyed by strong direct-to-consumer sales. The apparel maker's shares are up approximately 20% year-to-date, according to market data. ### Viking Holdings Ltd (VIK.US) Viking Holdings delivered strong first-quarter 2026 financial results, with total revenue increasing 17.5% year-over-year to USD 1.05 billion. The cruise operator is entering the summer season with 92% of its 2026 capacity already booked, representing USD 6.20 billion in advance bookings. Viking's stock has trended upward by nearly 40% since the start of the year, reflecting robust demand across its ocean and river itineraries. ### ENOVIX CORP (ENVX.US) Enovix is nearing the commercial scale-up of its next-generation silicon battery technology, opening a new USD 1.20 billion manufacturing facility in Malaysia this year. The company is scheduled to report its second-quarter 2026 results in August. While still in a pre-revenue intensive development phase, Enovix is targeting smart glasses and AI-driven devices. Shares have recently rebounded from previous lows over the past month. ### JINKOSOLAR HOLDING CO LTD SPON ADS EACH REPR 4 ORD SHS (JKS.US) JinkoSolar reported cumulative module shipments of approximately 400 gigawatts by the first quarter of 2026. The company recently received advanced hail and shading resistance validation for its Tiger Neo 3.0 modules, according to industry reports. Shares of the solar module maker have experienced volatility amid broader renewable energy sector pressures and trade uncertainties. ### STANDARD BIOTOOLS INC (LAB.US) Standard BioTools recently reached an agreement to sell its mass cytometry business to Multiplex Bio in a deal valued at up to USD 10 million. Concurrently, the life sciences company is navigating a merger agreement with Treeline Biosciences, slated for regulatory progression in late 2026. The company also received roughly USD 30 million related to an earn-out provision from Illumina. Shares have remained stable following these corporate actions. ### YSX TECH CO LTD (YSXT.US) YSX Tech reported a 16.8% increase in full-year revenue for 2026, driven by its digital automotive insurance services in China. The company is actively expanding its footprint, registering its trademark in the US earlier this year to support global brand initiatives. Shares have seen moderate trading volumes as the firm aims to capture higher margins in value-added aftermarket services. ### CHINA PHARMA HLGS INC (CPHI.US) China Pharma Holdings generated USD 4.14 million in revenue for its 2025 fiscal period, representing a decline from the prior year, and previously implemented a 1-for-10 reverse stock split. The pharmaceutical manufacturer recently filed for a USD 5 million follow-on equity offering to bolster its balance sheet. The micro-cap stock has trended lower throughout the year amid constrained financial performance. ### BLUEJAY DIAGNOSTICS INC (BJDX.US) Bluejay Diagnostics remains focused on scaling its Symphony clinical platform, closing a USD 23.7 million private placement in mid-2026 to fund ongoing operations. The medical device company completed enrollment of over 500 patients in its SYMON II study earlier this year. Shares have faced significant downside pressure, falling over 60% year-to-date as the company awaits regulatory clearance. ### SELECT SECTOR SPDR TRUST SST CNSMR DISCRETIONARY SLCT SCTR SPDR E (XLY.US) The Consumer Discretionary Select Sector SPDR Fund continues to track major macro trends across retail and leisure. As of mid-2026, the ETF's performance is heavily influenced by the resilient spending data reported by its top holdings, including Amazon and Tesla. The fund has posted steady single-digit gains year-to-date, reflecting cautious but stable consumer sentiment in the broader US economy. Capital flows in 2026 indicate a structural pivot among institutional investors. According to market data, portfolios are rotating away from hyper-growth narratives toward defensive industrial baselines and profitable consumer discretionary assets, rewarding firms that successfully execute price realization. _This article does not constitute investment advice._ ### Related Stocks - [ENVX.US](https://longbridge.com/en/quote/ENVX.US.md) - [LAB.US](https://longbridge.com/en/quote/LAB.US.md) - [JKS.US](https://longbridge.com/en/quote/JKS.US.md) - [YSXT.US](https://longbridge.com/en/quote/YSXT.US.md) - [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md) - [VIK.US](https://longbridge.com/en/quote/VIK.US.md) - [XYL.US](https://longbridge.com/en/quote/XYL.US.md) - [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md) - [LEVI.US](https://longbridge.com/en/quote/LEVI.US.md) ## Related News & Research - [Royal Bank of Canada Has $569.21 Million Stake in Xylem Inc. $XYL](https://longbridge.com/en/news/294186754.md) - [Is Xylem (XYL) Undervalued As Its Simplification Drive Points To Higher Margins?](https://longbridge.com/en/news/293842045.md) - [Xylem Q2 revenue rises misses estimates](https://longbridge.com/en/news/294054779.md) - [XYL: Raised full-year guidance after strong 2Q earnings, margin expansion, and robust order growth](https://longbridge.com/en/news/294054554.md) - [XYL: Record EPS and margin expansion driven by strong U.S. demand and strategic portfolio actions](https://longbridge.com/en/news/294085872.md)